MedPath

Impact of Sperm DNA Integrity on Artificial Reproductive Treatment (ART)

Terminated
Conditions
Sperm DNA Impact on ART Outcomes
Registration Number
NCT00875095
Lead Sponsor
Northwell Health
Brief Summary

The purpose of this study is to establish a new criteria with which to judge the quality of sperm samples submitted for artificial reproductive treatments. It is believed that this type of testing can compliment the traditional semen analysis to better drive patient care.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
Male
Target Recruitment
8
Inclusion Criteria
  • needs interventions through artificial reproductive treatment to achieve a pregnancy
Exclusion Criteria
  • severly oligozoospermic patients

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Sperm DNA integrity1 day
Secondary Outcome Measures
NameTimeMethod
achievement of a successful pregnancy1 year

Trial Locations

Locations (1)

The Center for Human Reproduction

πŸ‡ΊπŸ‡Έ

Manhasset, New York, United States

The Center for Human Reproduction
πŸ‡ΊπŸ‡ΈManhasset, New York, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.